Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia

被引:71
作者
Lasocki, Sigismond [1 ,2 ]
Millot, Sarah [1 ]
Andrieu, Valerie [3 ]
Letteron, Philippe [1 ]
Pilard, Nathalie [1 ]
Muzeau, Francoise [1 ]
Thibaudeau, Olivier [4 ]
Montravers, Philippe [2 ]
Beaumont, Carole [1 ]
机构
[1] Univ Paris Diderot, INSERM, Ctr Rech Biomed Bichat Beaujon, U773, Paris, France
[2] Hop Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat, F-75877 Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Serv Hematol Biol, F-75877 Paris, France
[4] Hop Bichat Claude Bernard, AP HP, Serv Anat Pathol, F-75877 Paris, France
关键词
anemia; intensive care; hepcidin; erythropoietin; iron; ferroportin;
D O I
10.1097/CCM.0b013e31818103b9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Anemia in critically ill patients is frequent and consists of chronic disease associated with blood losses. These two mechanisms have opposite effects on iron homeostasis, especially on the expression of the iron regulatory hormone hepcidin. We developed a mouse model mimicking the intensive care anemia to explore iron homeostasis. Design: Experimental study. Setting. University-based research laboratory. Subjects: C57BL/6 mice. Interventions. Mice received either a single intraperitoneal injection of lipopolysaccharide followed I week later by zymosan, or were subjected to repeated phlebotomies by retro-orbital punctures, or both. Several subsets of mice were analyzed over a 14-day period to describe the mouse model of intensive care anemia. Additional mice received erythropoietin injections with or without the zymosan treatment and were killed at day 5, to perform a more detailed analysis. Measurements and Main Results. We observed anemia as soon as 5 days after zymosan injection, together with increased messenger RNA (mRNA) levels for interleukin-6 and hepcidin. Phlebotomies alone fully suppressed hepcidin mRNA expression. Interestingly, in mice treated with zymosan and phlebotomies, hepcidin expression was suppressed, despite the persistent increase in interleukin-6. Stimulation of erythropoiesis by erythropoietin injections also led to a decrease in hepcidin mRNA in zymosan-treated mice. In these situations combining inflammation and erythropoiesis stimulation, there was no change in ferroportin, the membrane iron exporter, at the mRNA level, whereas ferroportin protein increased. Macrophage iron stores (assessed by histology using diaminobenzidine staining, or by quantification of nonheme iron and ferritin concentrations) were depleted in the spleen. Conclusions: These results suggest that the erythroid factor dominates over inflammation for hepcidin regulation, and that iron could be mobilized in these situations combining inflammation and erythropoiesis stimulation.
引用
收藏
页码:2388 / 2394
页数:7
相关论文
共 37 条
[1]   Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial [J].
Auerbach, M ;
Ballard, H ;
Trout, JR ;
McIlwain, M ;
Ackerman, A ;
Bahrain, H ;
Balan, S ;
Barker, L ;
Rana, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1301-1307
[2]   Time course of hemoglobin concentrations in nonbleeding intensive care unit patients [J].
Ba, VN ;
Bota, DP ;
Mélot, C ;
Vincent, JL .
CRITICAL CARE MEDICINE, 2003, 31 (02) :406-410
[3]   Unrecognised iron deficiency in critical illness [J].
Bellamy, MC ;
Gedney, JA .
LANCET, 1998, 352 (9144) :1903-1903
[4]   Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients:: a study using positron emission tomography [J].
Beshara, S ;
Lundqvist, H ;
Sundin, J ;
Lubberink, M ;
Tolmachev, V ;
Valind, S ;
Antoni, G ;
Långström, B ;
Danielson, BG .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) :296-302
[5]   MEDICAL VAMPIRES [J].
BURNUM, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (19) :1250-1251
[6]   Anemia of the critically ill: "Acute" anemia of chronic disease [J].
Corwin, HL ;
Krantz, SB .
CRITICAL CARE MEDICINE, 2000, 28 (08) :3098-3099
[7]   The CRIT Study: Anemia and blood transfusion in the critically ill - Current clinical practice in the United States [J].
Corwin, HL ;
Gettinger, A ;
Pearl, RG ;
Fink, MP ;
Levy, MM ;
Abraham, E ;
MacIntyre, NR ;
Shabot, M ;
Duh, MS ;
Shapiro, MJ .
CRITICAL CARE MEDICINE, 2004, 32 (01) :39-52
[8]   Efficacy and safety of epoetin alfa in critically ill patients [J].
Corwin, Howard L. ;
Gettinger, Andrew ;
Fabian, Timothy C. ;
May, Addison ;
Pearl, Ronald G. ;
Heard, Stephen ;
An, Robert ;
Bowers, Peter J. ;
Burton, Paul ;
Klausner, Mark A. ;
Corwin, Michael J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (10) :965-976
[9]   Bench-to-bedside review:: Iron metabolism in critically ill patients [J].
Darveau, M ;
Denault, AY ;
Blais, N ;
Notebaert, É .
CRITICAL CARE, 2004, 8 (05) :356-362
[10]   Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin [J].
Delaby, C ;
Pilard, N ;
Gonçalves, AS ;
Beaumont, C ;
Canonne-Hergaux, F .
BLOOD, 2005, 106 (12) :3979-3984